# Rainbow Children's Medicare (RAINBOW) — Stock analysis > Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/rainbow ## Current market snapshot - Exchange: NSE - Country: India - Price: ₹1,244.4 - Change: -1.39% - As of: 2026-11-06 - 1D return: -1.39% - 5D return: +2.11% - 1M return: +1.11% - Latest complete quarter: fy27_q2 ## Faxioms Analysis _As of 2026-11-06_ ### Technical Outlook RAINBOW closed at ₹1258.0 on 2026-11-06, trading within a narrow range between ₹1233.2 and ₹1270.0. The daily technical setup is mixed: while the price remains above the 20-period EMA and SMA, it is below the 50-period EMA, 200-period SMA, and the Supertrend, which signals a bearish bias. Daily trend strength is established (ADX 33.46), but the directional movement is neutral, with Minus DI (19.13) slightly edging out Plus DI (18.04). On a higher timeframe, the monthly structure is bullish (Supertrend up), whereas the weekly view is bearish (Supertrend down). Price is positioned in the upper-middle of its 20-day range (+73.1%) but in the lower-middle of its 252-day range (+33.1%). A recent extreme upward gap on 2026-11-03 (+0.6% return, Z-score 4.18) suggests residual volatility, though an active monthly Inside Bar pattern indicates consolidation. Key resistance lies near ₹1271.03 (pivot, +1.04%), with support at ₹1245.07 (-1.03%). - Daily Trend Conflict: Price is above short-term averages (20 EMA/SMA) but below key long-term levels (50 EMA, 200 SMA, Supertrend), indicating a tug-of-war between short-term bounce and medium-term downtrend. - Range Positioning: Trading at +73.1% of the 20-day range but only +33.1% of the 252-day range, suggesting recent relative strength against a longer-term weakness. - Key Levels: Immediate resistance at ₹1271.03 (+1.04%) and support at ₹1245.07 (-1.03%); a break above ₹1271.03 could signal renewed momentum, while a drop below ₹1245.07 may test ₹1234.93. - Volatility & Risk: Annualized volatility stands at +26.0% with a current drawdown of -23.1%; the recent extreme upward gap highlights heightened sensitivity to news or volume spikes. - Inside Bar - Outside Bar - Harami - Shooting Star - Bullish Engulfing Reversal - Morning Star ### News Context Rainbow Children's Medicare reported Q2 FY27 results for the July–September period, showing a 10.93% rise in net profit to ₹83.89 crore and a 23.2% increase in revenue to ₹548.02 crore. The company also commenced operations at new hospitals in Nellore and Guntur, expanding its footprint in coastal Andhra Pradesh. On the analyst front, Prabhudas Lilladher issued a 'Buy' recommendation with a target price of ₹1,650 on November 3. Additionally, Economic Times highlighted Rainbow as one of six stocks where mutual fund holdings have risen for four consecutive quarters since September 2025, noting this accumulation occurred despite broader market slumps driven by geopolitical tensions and inflationary pressures. - Q2 FY27 Net Profit: ₹83.89 crore (up 10.93% YoY); Revenue: ₹548.02 crore (up 23.2% YoY). - Operational Expansion: New hospitals opened in Nellore and Guntur, strengthening presence in coastal Andhra Pradesh. - Analyst View: Prabhudas Lilladher assigned a 'Buy' rating with a ₹1,650 target price on November 3, 2026. - Institutional Interest: Mutual fund holdings increased for four consecutive quarters ending September 2026, identified as a resilient pick amid market volatility. - [Buy Rainbow Childrens Medicare; target of Rs 1650: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-rainbow-childrens-medicare-target-of-rs-1650-prabhudas-lilladher-14067540.html) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump](https://economictimes.indiatimes.com/mf/analysis/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135444961.cms) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump - The Economic Times](https://economictimes.indiatimes.com/wealth/invest/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135386027.cms) - [Rainbow Children's Medicare Q2 results: Profit rises to ₹84 cr](https://www.thehindubusinessline.com/companies/rainbow-childrens-medicare-q2-results-profit-rises-to-84-cr/article71652182.ece) - [Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results](https://www.thehindubusinessline.com/markets/q2-results-today-live-updates-ntpc-muthoot-finance-shyam-metalics-amp-energy-sarda-energy-and-minerals-zen-technologies-national-securities-depository-rainbowc-childrens-medicare-company-results-31-oc/article71648157.ece) ### Official Filings Rainbow Children's Medicare Limited reported unaudited financial results for the quarter and half year ended September 30, 2026, alongside significant operational expansions and leadership changes. For Q2 FY27, consolidated revenue from operations rose 23.2% year-over-year to ₹5,480.2 million, while profit after tax increased 10.9% to ₹838.9 million. EBITDA excluding other income grew 14.2% to ₹1,699.8 million. The first half of FY27 saw revenue reach ₹10,180.1 million (up 27.6%) and PAT at ₹1,464.3 million (up 13.1%). Operationally, the company commenced activities at three new facilities: Rainbow Nellore (55 operational beds), Rainbow Guntur (40 operational beds), and Rainbow HRBR (48 operational beds). Additionally, a proposed 150-bed specialty pediatric hospital in Amaravati has entered project planning following the allotment of two acres by the Government of Andhra Pradesh. Governance-wise, Mr. Sudarshan Patodia was appointed as Group CFO. These filings were submitted to the NSE on October 31, 2026, with subsequent investor presentations and earnings call recordings made available on November 2, 2026. - Q2 FY27 Revenue Growth: Consolidated revenue from operations reached ₹5,480.2 million, up 23.2% year-over-year; H1 FY27 revenue was ₹10,180.1 million, up 27.6%. - Profitability Metrics: Q2 FY27 Profit After Tax was ₹838.9 million (up 10.9%); H1 FY27 PAT was ₹1,464.3 million (up 13.1%). - Operational Expansion: Three new hospitals commenced operations—Rainbow Nellore (55 beds), Rainbow Guntur (40 beds), and Rainbow HRBR (48 beds)—with a proposed 150-bed facility in Amaravati entering project planning. - Leadership Change: Mr. Sudarshan Patodia appointed as Group CFO, disclosed in revised press release filed on October 31, 2026. - [Rainbow Children's Medicare Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results for the quarter and half year ended September 30, 2026. |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026104606_Intimation.pdf) - [RAINBOW CHILDRENS MEDICARE LIMITED has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261102_180555200.xml) - [Rainbow Children's Medicare Limited has informed the Exchange about Link of Recording of Earnings Conference Call for the quarter and half year ended September 30, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026181311_IntimationAC.pdf) - [Rainbow Childrens Medicare Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended September 30, 2026 |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026184309_IntimationFR.pdf) - [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750781_31102026065840_WEB.xml) - [Integrated Filing- Financials|Revision|The meeting start and end time were inadvertently mentioned incorrectly. The correct timings are 4:45 PM to 5:15 PM which is updated in the revised XBRL.](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750789_31102026070422_WEB.xml) - [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750791_31102026070620_WEB.xml) - [Rainbow Childrens Medicare Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026194922_IntimationInvestorpresentation.pdf) - [Rainbow Children's Medicare Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Press Release on Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended September 30, 2026.". |SUBJECT: Press Release](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026195451_IntimationPressrelease.pdf) - [Rainbow Childrens Medicare Limited has informed the Exchange regarding a revised press release dated October 31, 2026, titled "Revised Press Release on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.". |SUBJECT: Press Release (Revised)](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026200311_IntimationPressreleaserev.pdf) ### Fundamentals Rainbow Childrens Medicare demonstrates a strong operational upswing in Q2 FY2026-27, with revenue from operations surging to ₹548 crore, up 23% year-on-year. This growth is accompanied by robust earnings expansion: operating profit rose to ₹170 crore and net profit reached ₹84 crore, driving EPS to ₹8.08. The company’s cash conversion remains high, with CFO/EBITDA consistently near 95%, indicating that reported profits are translating effectively into cash. On the balance sheet, the firm is actively investing for future capacity, evidenced by Capital Work In Progress (CWIP) rising to ₹103 crore and Fixed Assets increasing to ₹1,886 crore as of September 2026. Borrowings have also grown to ₹968 crore to support this expansion. While working capital efficiency has improved significantly—working capital days dropped to just 8—the inventory cycle lengthened to 67 days, potentially reflecting stock buildup ahead of sales. Institutional sentiment shows a shift, with DIIs increasing their stake to 23.28% while FIIs reduced theirs to 14.66%. - Revenue grew 23% YoY to ₹548 crore in Q2 FY2026-27, with net profit rising to ₹84 crore. - Cash flow quality remains strong, with CFO/EBITDA at 95% for the last three fiscal years. - Balance sheet reflects aggressive capex: CWIP increased to ₹103 crore and borrowings rose to ₹968 crore. - Inventory days extended to 67 days in Mar 2026, contrasting with a sharp improvement in working capital days to 8. ### Bull Case Rainbow Childrens Medicare presents a conditional upside case anchored by robust operational expansion and sustained institutional confidence, despite near-term technical weakness. For the July-September quarter, revenue grew 23.2% to ₹548.02 crore, while net profit rose 10.93% to ₹83.89 crore. This growth coincides with the commencement of operations at new hospitals in Nellore and Guntur, signaling successful geographic diversification into coastal Andhra Pradesh. Furthermore, mutual fund holdings have increased for four consecutive quarters since September 2025, indicating that long-term capital providers view the stock as resilient amid broader market slumps. Technically, while daily and weekly trends are bearish with the price at ₹1,258, the monthly trend remains bullish, suggesting that the current correction may be a medium-term consolidation rather than a structural breakdown. The constructive interpretation holds if the company can sustain its revenue momentum from new facilities and if institutional buying continues to provide a floor against short-term volatility. - Q2 Revenue Growth: Revenue increased 23.2% to ₹548.02 crore, driven by operational expansion including new hospitals in Nellore and Guntur. - Institutional Accumulation: Mutual fund holdings have risen for four consecutive quarters since September 2025, highlighting long-term conviction despite market headwinds. - Monthly Technical Resilience: While daily and weekly trends are bearish, the monthly Supertrend remains bullish, offering a potential medium-term support structure. - Profitability Maintenance: Net profit reached ₹83.89 crore (up 10.93%), demonstrating ability to grow earnings even as revenue scales rapidly. - [Buy Rainbow Childrens Medicare; target of Rs 1650: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-rainbow-childrens-medicare-target-of-rs-1650-prabhudas-lilladher-14067540.html) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump](https://economictimes.indiatimes.com/mf/analysis/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135444961.cms) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump - The Economic Times](https://economictimes.indiatimes.com/wealth/invest/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135386027.cms) - [Rainbow Children's Medicare Q2 results: Profit rises to ₹84 cr](https://www.thehindubusinessline.com/companies/rainbow-childrens-medicare-q2-results-profit-rises-to-84-cr/article71652182.ece) - [Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results](https://www.thehindubusinessline.com/markets/q2-results-today-live-updates-ntpc-muthoot-finance-shyam-metalics-amp-energy-sarda-energy-and-minerals-zen-technologies-national-securities-depository-rainbowc-childrens-medicare-company-results-31-oc/article71648157.ece) - [Rainbow Children's Medicare Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results for the quarter and half year ended September 30, 2026. |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026104606_Intimation.pdf) - [RAINBOW CHILDRENS MEDICARE LIMITED has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261102_180555200.xml) - [Rainbow Children's Medicare Limited has informed the Exchange about Link of Recording of Earnings Conference Call for the quarter and half year ended September 30, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026181311_IntimationAC.pdf) - [Rainbow Childrens Medicare Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended September 30, 2026 |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026184309_IntimationFR.pdf) - [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750781_31102026065840_WEB.xml) ### Bear Case Rainbow Childrens Medicare faces significant near-term technical headwinds, with the stock trading in a bearish daily and weekly trend as of November 6, 2026. The share price has declined 19.1% since the start of the period and is currently 23.1% below its recent peak, reflecting substantial investor drawdown. While quarterly fundamentals remain robust—with Q2 revenue rising 23.2% to ₹548.02 crore and net profit increasing 10.93% to ₹83.89 crore—the market pricing suggests caution. Technical indicators show the stock is under pressure, with the daily SuperTrend signaling bearish momentum and the 50-day moving average slope steeply negative at -19.37. Although mutual fund holdings have risen for four consecutive quarters through September 2026, indicating institutional accumulation during the slump, the immediate price action remains weak, testing support levels around ₹1,245. - Technical Deterioration: Daily and weekly trends are bearish; the stock is down 19.1% from the period start and 23.1% from its high, with a current price of ₹1,258. - Moving Average Pressure: The 50-day simple moving average shows a steep negative slope of -19.37, while the 20-day EMA slope is positive but insufficient to counter the broader downtrend. - Institutional Accumulation Amid Slump: Mutual funds increased holdings for four consecutive quarters ending September 2026, buying into the market decline driven by geopolitical and inflationary pressures. - Fundamental Resilience vs. Price Action: Despite strong Q2 performance (revenue +23.2%, profit +10.93%) and new hospital openings, the stock has underperformed the broader market context, yielding a YTD return of -4.4%. - [Buy Rainbow Childrens Medicare; target of Rs 1650: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-rainbow-childrens-medicare-target-of-rs-1650-prabhudas-lilladher-14067540.html) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump](https://economictimes.indiatimes.com/mf/analysis/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135444961.cms) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump - The Economic Times](https://economictimes.indiatimes.com/wealth/invest/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135386027.cms) - [Rainbow Children's Medicare Q2 results: Profit rises to ₹84 cr](https://www.thehindubusinessline.com/companies/rainbow-childrens-medicare-q2-results-profit-rises-to-84-cr/article71652182.ece) - [Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results](https://www.thehindubusinessline.com/markets/q2-results-today-live-updates-ntpc-muthoot-finance-shyam-metalics-amp-energy-sarda-energy-and-minerals-zen-technologies-national-securities-depository-rainbowc-childrens-medicare-company-results-31-oc/article71648157.ece) - [Rainbow Children's Medicare Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results for the quarter and half year ended September 30, 2026. |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026104606_Intimation.pdf) - [RAINBOW CHILDRENS MEDICARE LIMITED has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261102_180555200.xml) - [Rainbow Children's Medicare Limited has informed the Exchange about Link of Recording of Earnings Conference Call for the quarter and half year ended September 30, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026181311_IntimationAC.pdf) - [Rainbow Childrens Medicare Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended September 30, 2026 |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026184309_IntimationFR.pdf) - [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750781_31102026065840_WEB.xml) ### FAQs **What were Rainbow Childrens Medicare's financial results for the July-September 2026 quarter?** For the quarter ended September 30, 2026, the company reported a net profit of ₹83.89 crore, a 10.93% increase from the prior period. Revenue rose 23.2% to ₹548.02 crore. These unaudited consolidated results were submitted to the NSE on October 31, 2026. **How has institutional investor interest in Rainbow Childrens Medicare changed recently?** Mutual fund holdings in the stock have risen for four consecutive quarters ending September 2026. The Economic Times identified it as one of six 'most wanted' stocks with consistently rising institutional ownership, even amid broader market slumps driven by geopolitical and inflationary pressures. **What is the current technical trend and price action for RAINBOW shares?** As of November 6, 2026, the daily trend is bearish with the share closing at ₹1,258.00. The stock is down -7.8% over the past year and -20.0% over three months, with a current drawdown of -23.1%. However, the monthly trend remains bullish, and resistance is noted near ₹1,271. **Are there any analyst recommendations or new operational developments?** Prabhudas Lilladher issued a 'Buy' recommendation with a target price of ₹1,650. Operationally, the company commenced hospital operations in Nellore and Guntur during Q2 FY27, strengthening its presence in coastal Andhra Pradesh. - [Buy Rainbow Childrens Medicare; target of Rs 1650: Prabhudas Lilladher](https://www.moneycontrol.com/news/business/stocks/buy-rainbow-childrens-medicare-target-of-rs-1650-prabhudas-lilladher-14067540.html) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump](https://economictimes.indiatimes.com/mf/analysis/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135444961.cms) - [Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump - The Economic Times](https://economictimes.indiatimes.com/wealth/invest/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135386027.cms) - [Rainbow Children's Medicare Q2 results: Profit rises to ₹84 cr](https://www.thehindubusinessline.com/companies/rainbow-childrens-medicare-q2-results-profit-rises-to-84-cr/article71652182.ece) - [Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results](https://www.thehindubusinessline.com/markets/q2-results-today-live-updates-ntpc-muthoot-finance-shyam-metalics-amp-energy-sarda-energy-and-minerals-zen-technologies-national-securities-depository-rainbowc-childrens-medicare-company-results-31-oc/article71648157.ece) - [Rainbow Children's Medicare Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results for the quarter and half year ended September 30, 2026. |SUBJECT: Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026104606_Intimation.pdf) - [RAINBOW CHILDRENS MEDICARE LIMITED has informed the Exchange about Audio Recording/Video Recording |SUBJECT: Analyst/Investor Meet Para A-XBRL](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261102_180555200.xml) - [Rainbow Children's Medicare Limited has informed the Exchange about Link of Recording of Earnings Conference Call for the quarter and half year ended September 30, 2026. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026181311_IntimationAC.pdf) - [Rainbow Childrens Medicare Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended September 30, 2026 |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026184309_IntimationFR.pdf) - [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750781_31102026065840_WEB.xml) ## Technical analytics - As of: 2026-11-06 - Daily trend: Weak Uptrend - Weekly trend: Weak Downtrend - Pivot point: ₹1,271.03 - Risk regime: Price Risk Requires Attention ### Support levels - 1234.930859375 - 1218.2375 - 1190.2 ### Resistance levels - 1334.15 - 1366.45 - 1397.674609375 ### Return and range metrics | Metric | Value | | --- | --- | | return_1 | -1.39% | | return_10 | +6.40% | | return_1m | +0.38% | | return_1y | -8.75% | | return_20 | +1.11% | | return_3m | -20.90% | | return_5 | +2.11% | | return_6m | -3.04% | | return_since_start | -19.95% | | return_ytd | -5.40% | ### Risk and volatility metrics | Metric | Value | | --- | --- | | state | elevated_risk | | label | Price risk requires attention | | summary | Recent drawdown or price variability is high enough to warrant closer monitoring. | | maximum_drawdown | -32.53% | | annualized_volatility | +26.06% | ## Quarterly financials - Latest complete quarter: fy27_q2 # Rainbow Childrens Medicare Limited Q2 FY2026-27: Revenue up 23%, profit up 11% Rainbow Childrens Medicare reported Q2 FY2026-27 revenue from operations of ₹548.0 crore, up 23.2% year on year, while profit for the period rose 10.9% to ₹83.9 crore. Sequentially, revenue increased 16.6% and profit rose 34.1%; however, expenses grew faster than revenue year on year, and pre-tax profit growth was more modest at 8.9%. ## Revenue and expenses Revenue from operations was ₹548.0 crore, compared with ₹470.0 crore in Q1 FY2026-27 and ₹444.8 crore in Q2 FY2025-26. Total income, including ₹8.1 crore of other income, was ₹556.1 crore, up 15.2% sequentially and 22.8% year on year. Total expenses rose 11.5% sequentially to ₹444.6 crore from ₹398.7 crore in Q1 FY2026-27. Year on year, expenses increased 26.8%, faster than the 23.2% rise in revenue from operations—a cost trend that tempered pre-tax profit growth. ## Profit and earnings Profit before tax was ₹111.5 crore, up 32.8% from ₹84.0 crore in Q1 FY2026-27 and 8.9% from ₹102.4 crore in Q2 FY2025-26. Finance costs increased 3.7% sequentially to ₹22.0 crore and 16.7% year on year. Profit for the period rose to ₹83.9 crore from ₹62.5 crore in Q1 FY2026-27 and ₹75.6 crore in Q2 FY2025-26. Of Q2 profit, ₹82.1 crore was attributable to owners of the parent and ₹1.8 crore to non-controlling interests. Basic and diluted earnings per share were ₹8.10, compared with ₹5.97 in Q1 FY2026-27 and ₹7.41 in Q2 FY2025-26. ## Tax Tax expense was ₹27.6 crore, up 28.9% from Q1 FY2026-27 and 3.2% from Q2 FY2025-26. It comprised current tax of ₹33.2 crore, partly offset by a deferred tax credit of ₹5.6 crore. ## Cash flow and liquidity Operating activities generated ₹217.8 crore in Q2 FY2026-27. Investing activities used ₹87.0 crore and financing activities used ₹132.2 crore; reported free cash flow was ₹130.8 crore. At 30 September 2026, cash and cash equivalents were ₹32.6 crore, compared with ₹33.9 crore at 31 March 2026 and ₹26.8 crore at 30 September 2025. Current investments stood at ₹353.6 crore, down from ₹404.5 crore at 31 March 2026 and ₹415.5 crore at 30 September 2025. ## Balance sheet and investment Total assets stood at ₹2,958.6 crore at 30 September 2026, up from ₹2,774.8 crore at 31 March 2026 and ₹2,586.7 crore at 30 September 2025. Property, plant and equipment increased to ₹1,669.0 crore from ₹1,561.6 crore at March-end, while capital work in progress rose to ₹102.9 crore from ₹75.8 crore. Total equity was ₹1,735.9 crore, compared with ₹1,663.6 crore at 31 March 2026. Trade receivables increased to ₹133.4 crore from ₹103.2 crore over the same period, while inventories rose to ₹53.7 crore from ₹41.6 crore. ## Key Takeaway Rainbow delivered strong sequential growth in revenue and profit, while year-on-year revenue growth exceeded profit growth as expenses rose faster than sales. Higher fixed assets and equity indicate a larger balance sheet, alongside increased receivables and inventories; cash and current investments were lower than at March-end. ### Ratios ## Shareholding pattern - Quarter: FY2027-Q2 - As of: 2026-09-30 - Promoter holding: +49.83% - FII holding: +14.66% - DII holding: +23.28% - Mutual fund holding: +18.84% - Retail holding: +5.53% - Promoter pledged: +0.00% ### Major reported shareholders - RAMESH KANCHARLA — +31.03% - CHIRLA DINESH KUMAR PADMARAO — +6.53% - ADARSH KANCHARLA — +6.02% - ICICI PRUDENTIAL HEALTHCARE FUND — +5.50% - RAMESH KANCHARLA — +5.13% (Trusts) - DSP FLEXI CAP FUND — +3.42% - FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND — +2.20% - HDFC LIFE INSURANCE COMPANY LIMITED — +2.10% - ABU DHABI INVESTMENT AUTHORITY - MONSOON — +2.06% - TITANIUM EQUITY LONG-SHORT FUND — +1.88% ## Official filings - 2026-11-06 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_06112026180341_Intimationtranscript.pdf) - 2026-11-06 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261106_180532782.xml) - 2026-11-02 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026104606_Intimation.pdf) - 2026-11-02 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261102_180555200.xml) - 2026-11-02 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_02112026181311_IntimationAC.pdf) - 2026-10-31 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026184309_IntimationFR.pdf) - 2026-10-31 — Financial Results Filing: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750781_31102026065840_WEB.xml) - 2026-10-31 — Financial Results Filing: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750789_31102026070422_WEB.xml) - 2026-10-31 — Financial Results Filing: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1750791_31102026070620_WEB.xml) - 2026-10-31 — Earnings Presentation: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026194922_IntimationInvestorpresentation.pdf) - 2026-10-31 — Press Release: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026195451_IntimationPressrelease.pdf) - 2026-10-31 — Press Release: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_31102026200311_IntimationPressreleaserev.pdf) - 2026-10-23 — Board Meeting Notice: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_23102026170409_IntimationPI.pdf) - 2026-10-23 — Board Meeting Notice: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_20296_WebXMLFile_20261023_170623135.xml) - 2026-10-23 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_20296_WebXMLFile_20261023_170623135.xml) - 2026-10-23 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_20296_WebXMLFile_20261023_172849979.xml) - 2026-10-23 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_23102026172558_IntimationInv.pdf) - 2026-10-14 — Shareholding Disclosure: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SHP_1737357_14102026101847_WEB.xml) - 2026-10-09 — Financial Results Filing: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1735225_09102026075032_WEB.xml) - 2026-10-09 — Financial Results Filing: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1735226_09102026075226_WEB.xml) - 2026-10-07 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_07102026111021_Intimation.pdf) - 2026-09-30 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_30092026133557_Intimationamaravathi.pdf) - 2026-09-29 — Credit Rating Update: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_29092026185142_CRintimation.pdf) - 2026-09-25 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/RAINBOWUSER_25092026102028_IntimationTWC.pdf) - 2026-09-25 — Generic Announcement: Rainbow Childrens Medicare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/CLOSURE_TRADING_WINDOW_20296_WebXMLFile_20260925_102606608.xml) ## News and market events - 2026-11-03 — MONEYCONTROL: **Buy Rainbow Childrens Medicare; target of Rs 1650: Prabhudas Lilladher** — Prabhudas Lilladher has issued a 'Buy' recommendation for Rainbow Childrens Medicare, setting a target price of Rs 1650. — [Source](https://www.moneycontrol.com/news/business/stocks/buy-rainbow-childrens-medicare-target-of-rs-1650-prabhudas-lilladher-14067540.html) - 2026-11-02 — Economic Times: **Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump** — Six stocks including KFin Technologies, Rainbow Children’s Medicare, Indus Towers, Timken India, SBI Cards & Payment Services, and Mahindra & Mahindra have seen a gradual rise in mutual fund holdings for four consecutive quarters since September 2025. This investment activity occurs amid a broader market slump driven by geopolitical tensions, inflationary pressures, and hawkish monetary policy shifts. — [Source](https://economictimes.indiatimes.com/mf/analysis/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135444961.cms) - 2026-11-02 — Economic Times: **Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump - The Economic Times** — Economic Times identified six stocks with consistently rising mutual fund holdings over the past four quarters as of September 2026, highlighting them as resilient picks amid a broader market slump. — [Source](https://economictimes.indiatimes.com/wealth/invest/most-wanted-stocks-2026-6-stocks-mutual-funds-are-buying-even-as-markets-slump/articleshow/135386027.cms) - 2026-11-01 — The Hindu: **Rainbow Children's Medicare Q2 results: Profit rises to ₹84 cr** — Rainbow Children's Medicare Limited reported a 10.93% rise in net profit to ₹83.89 crore and a 23.2% increase in revenue to ₹548.02 crore for the July-September quarter. The company also commenced operations at new hospitals in Nellore and Guntur, strengthening its presence in coastal Andhra Pradesh. — [Source](https://www.thehindubusinessline.com/companies/rainbow-childrens-medicare-q2-results-profit-rises-to-84-cr/article71652182.ece) - 2026-10-31 — The Hindu: **Q2 Results Today Live: NTPC, Muthoot Finance, Shyam Metalics & Energy, Sarda Energy and Minerals, Zen Technologies, National Securities Depository, Rainbow Childrens Medicare Share to announce Q2 results** — Syrma SGS has set a target of $1 billion in revenue for the next year, driven by strong growth in H1 and record Q2 FY27 results despite component shortages and PCB bottlenecks. — [Source](https://www.thehindubusinessline.com/markets/q2-results-today-live-updates-ntpc-muthoot-finance-shyam-metalics-amp-energy-sarda-energy-and-minerals-zen-technologies-national-securities-depository-rainbowc-childrens-medicare-company-results-31-oc/article71648157.ece) - 2026-07-31 — CNBC-TV18: **Q1 Results LIVE Updates: Sun Pharma reports earnings; Shree Cement shares fall, GAIL up nearly 4%** — Q1 Results LIVE Updates: Four Nifty companies, ITC, Maruti Suzuki, Sun Pharma and Bajaj Finserv report results today to round off this week dominated by earnings. Broader market names like Dixon Tech, Indian Oil, Glenmark Pharma, GMDC, ABB India, SJVN, GAIL and NALCO among many others will also be reporting their results. The big result reactions of the day include the likes of Swiggy, Mazagon Dock, Thermax, Bajaj Finance's earnings call and upgrades among others. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-sun-pharma-itc-maruti-suzuki-bajaj-finserv-tata-steel-swiggy-share-price-liveblog-19958383.htm) - 2026-07-31 — CNBC-TV18: **Sensex Today | Stock Market Live Updates: Nifty extends gains to 100 pts; PSU banks off lows** — Sensex Today | Stock Market Live Updates: We are the last half the week's trade, and the Indian markets are trading on a cautious note. The Nifty is looking to close the week in green, and is trading around 24,300. The Nifty Bank is trying to hold it together, now up around 100 points, moving around 57,250. TCS, Infosys and Wipro are the top laggards. — [Source](https://www.cnbctv18.com/market/stock-market-live-updates-sensex-nifty-50-today-it-infosys-banks-tata-steel-swiggy-sun-pharma-mdl-bajaj-fin-share-price-liveblog-19958369.htm) - 2026-07-30 — CNBC-TV18: **Q1 Results LIVE Updates: RailTel profit flat, Chambal Fertilisers margins expand** — Q1 Results LIVE Updates: Bajaj Finance, M&M and Tata Steel are the three Nifty results for the day, along with broader market names like Hyundai Motor, Vedanta, Vedanta Aluminium, Swiggy, Mazagon Dock, Torrent Pharma, Thermax and many others. Eicher Motors, Dabur, three Vedanta demerged units, Bajaj Housing, Hexaware and many more also react to numbers. Watch this space for all the LIVE Q1 results updates. — [Source](https://www.cnbctv18.com/market/q1-results-live-updates-today-bajaj-finance-mm-tata-steel-eicher-dabur-mazagon-dock-swiggy-syngene-irfc-vedanta-aluminium-mtar-hyundai-lic-liveblog-19957385.htm) - 2026-07-24 — Mint: **The Street resets its Nifty 500 bets. Here are the winners** — The optimism reflects the underperformance of Indian equities relative to other emerging markets and the US, along with a moderation in valuations. — [Source](https://www.livemint.com/market/stock-market-news/the-street-resets-its-nifty-500-bets-here-are-the-winners-indian-stock-market-11784798077110.html) ## Business profile **Strategic vision:** Specialized pediatric and obstetrics and gynecology hospital chain. ### Business segments - **Pediatric Tertiary and Quaternary Care:** Rainbow Hospitals provide comprehensive specialized pediatric services including intensive care, sub-specialties like neurology and oncology, and pediatric surgery. - **Obstetrics & Gynecology:** Through its 'BirthRight by Rainbow' brand, the company offers maternal care services including obstetrics, gynecology, fetal medicine, and reproductive medicine. ### Competitive strengths - Specialized multi-specialty pediatric and obstetrics and gynecology hospital chain. - Focus on tertiary and quaternary pediatric care and maternal health. - Hub-and-spoke clinical model for centralized complex care and distributed outpatient services. ## Related stocks - [Blue Jet Healthcare Limited (Healthcare)](https://faxioms.com/stocks/bluejet) — -3.23% - [Caplin Point Laboratories Limited (Healthcare)](https://faxioms.com/stocks/caplipoint) — -1.64% - [Cohance Lifesciences Limited (Healthcare)](https://faxioms.com/stocks/cohance) — -3.56% - [Concord Biotech Limited (Healthcare)](https://faxioms.com/stocks/concordbio) — -6.64% - [Eris Lifesciences Limited (Healthcare)](https://faxioms.com/stocks/eris) — +0.58% ## Freshness and sources - Data as of: 2026-11-06 - Source: Faxioms public stock analysis API Canonical: https://faxioms.com/stocks/rainbow Markdown representation: https://faxioms.com/stocks/rainbow?render=md